Patient info Search Menu

Cystadrops 3.8 mg/mL ey – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
3.8 mg/ml
Contains active substance:

Patient leaflet - Cystadrops 3.8 mg/ml eye drops solution

What it is used for

It is used to reduce the quantity of cystine crystals in

the surface of the eye (cornea) in adults and children

from 6 months of age with cystinosis.

What is cystinosis

Cystinosis is a rare hereditary disease in which the bo

dy is unable to remove excess cystine (an amino acid),

causing cystine crystals to accumulate in various orga

ns (such as kidney and eyes). Accumulation of crystals

in the eye can lead to increased sensitivity to light (p

hotophobia), corneal deterioration (keratopathy) and

loss of vision.

2. What you need to know before you us

e Cystadrops

Do not use Cystadrops

If you are allergic to cysteamine or any of the other i

ngredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before using Cysta

drops.

Other medicines and Cystadrops

Tell your doctor or pharmacist if you are using, have

recently used or might use any other medicines.

Pregnancy and breast-feeding

Even if the level of Cystadrops in the blood is negligi

ble, precautions should be taken.

If you are pregnant or breast-feeding, think you may

be pregnant or are planning to have a baby, ask your

doctor or pharmacist for advice before taking this me

dicine.

Driving and using machines

You may find that your vision is blurred for a few mi

nutes just after using Cystadrops. Do not drive or use

machines until your vision is clear.

Cystadrops contains benzalkonium chloride

This medicine contains 5 micrograms benzalkonium c

hloride in each drop which is equivalent to 0.1 mg/ml.

Benzalkonium chloride may be absorbed by soft con

tact lenses and may change the colour of the contact

lenses. You should remove contact lenses before using this medicine and put them back 15 minutes afterwards.

Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.

3. How to use Cystadrops

Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

  • The recommended dose is 1 drop in each eye, 4 times a day during waking hours.
  • The recommended interval between each application is 4 hours (for example, you can have your eye drops at 8.00 am, 12.00 am, 4.00 pm and 8.00 pm).

    • To avoid sticky eyes in the morning, it is recommended to apply the last drop of the day at least 30 minutes before going to bed.
    • The dose may be gradually decreased (to a minimum total daily dose of 1 drop in each eye) by your doctor based on eye examinations.

Only use the drops in your eyes (ocular use).

To use the eye drops, please follow the instructions below carefully.

Those instructions are also available as an animated movie on www.cystadrops.net

Step 1: Before using a vial for the first time

  • Cystadrops must be brought back at room temperature before the first administration. It will facilitate the use of the drops.
  • Immediately before using a vial for the first time, write the date of opening in the space provided on the

carton box.

  • Wash your hands carefully in order to avoid contami

nation by bacteria of the content in the vial.

  • Remove the green protective cap (picture 1).
  • Remove the metal seal (picture 2).
  • Remove the grey stopper (picture 3) from the vial.
  • Do not touch the opening of the vial after removing

the grey stopper.

turn and push to attach small white cap

small white cap dropper dropper vial

vial

➃ ➄

grey

stopper

➂

re

move

metal

seal

➁

remove

green

protective

cap

vial

➀

remove

  • Take the dropper out of its sachet, without touching t

he end intended to be attached to the vial, and attach

it (picture 4) to the vial. Do not remove the dropper

from the vial.

  • Make sure that you do not lose the small white cap (

picture 5) that comes on the top of the dropper.

Step 2: Before using the eye drops

  • Check the opening date that you wrote down on th

e carton box. Cystadrops can be used for up to 7 days

from the time of opening.

  • Get the dropper bottle and a mirror.
  • Wash your hands.

Step 3: Using the eye drops

  • Hold the dropper bottle, pointing down, between yo

ur thumb and fingers. Move firmly the dropper bottle

up and down to facilitate the filing of the dropper.
  • Unscrew the small white cap from the dropper.
  • Tilt your head back. Pull down your eyelid with a cle

an finger, until there is a “pocket” between the eyelid

and your eye. The drop will go in here (picture 6).

  • Bring the dropper bottle tip close to the eye. Use the

mirror if it helps.

  • Do not touch your eye or eyelid, surrounding are

as or other surfaces with the dropper. It could infect

the drops.

  • Gently squeeze the dropper to release one drop of C

ystadrops at a time. Take special care not to touch the

tip of the dropper with your fingers.

  • After using Cystadrops, press a finger into the corner o

f your eye by the nose (picture 7), then gently massage

your upper eyelid to spread the eye drops over the e

ye.

  • To avoid potential irritation, remove excess medicin

e around the eye with a moist tissue (picture 8).

  • Repeat the step 3 for the other eye.
  • Replace the small white cap on the dropper immedi

ately after use.

➅ ➆ ➇

Step 4: Storing the eye drops after use

  • Place the dropper bottle into the carton box.
  • Keep Cystadrops at room temperature (it will facilitate the use of the dropper).
  • Discard 7 days after opening.

If a drop misses your eye

Try again.

If you use Cystadrops with another eye medicine

Ensure that there is at least a 10 minute gap between using Cystadrops and the other eye medicine. Administer eye ointments last.

If you wear soft contact lenses

Do not use the drops with your lenses in. After using the drops wait 15 minutes before putting your lenses back in.

If you use more Cystadrops than you should

If you put too many drops in your eyes, rinse your eyes out, preferably with saline solution (or if not available with warm water). Do not put in any more drops until it is time for your next regular dose.

If you forget to use Cystadrops

Wait for your next scheduled application and then co

ntinue with your regular routine. Do not use a double

dose to make up for a forgotten dose.

If you stop using Cystadrops

Cystadrops must be used every day for the medicine

to work properly. If you stop using Cystadrops, cystine

crystals accumulation in the eye (cornea) may increase

and lead to increased sensitivity to light (photophobia),

corneal deterioration (keratopathy) and loss of visio

n. Therefore talk to your doctor before stopping this

treatment.

If you have any further questions on the use of this m

edicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effec

ts, although not everybody gets them.

You can usually carry on taking the drops, unless the e

ffects are serious. If you are worried, talk to your doctor

or pharmacist. Do not stop using Cystadrops withou

t speaking to your doctor.

The following side effects were reported:

Very common side effects (may affect more than 1

in 10 people)
  • eye pain
  • eye redness, eye itching, eye irritation (burning)
  • watery eyes
  • blurred vision
  • discomfort where the drops have been instilled (mai
nly sticky eyes and sticky eyelashes), medicine deposit

on the eyelashes, around the eyes

Common side effects (may affect up to 1 in 10 peop

le)
  • abnormal sensation in eye, a feeling of something i
n the eye
  • dry eyes
  • swollen eyelid
  • irritation of eyelid
  • visual impairement
  • pain where the drops have been instilled
  • stye

Reporting of side effects

If you get any side effects, talk to your doctor or ph

armacist. This includes any possible side effects not

listed in this leaflet. You can also report side effects d

irectly via the national reporting system Yellow Card

Scheme Website: www.mhra.gov.uk/yellowcard or se

arch for MHRA Yellow Card in the Google Play or Apple

App Store. By reporting side effects you can help pro

vide more information on the safety of this medicine.

5. How to store Cystadrops

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the vial label and the carton after EXP.

Before opening:

  • Store in a refrigerator (2°C - 8°C).
  • Keep the vial in the outer carton in order to protect from light.

After first opening:

  • Write down the date you opened the vial in the space on the carton.
  • Cystadrops can be used for up to 7 days from the time of opening.
  • Keep the dropper bottle tightly closed in the outer carton in order to protect from light.
  • Store below 25°C.
  • Do not refrigerate.

    • You must throw away the dropper bottle 7 days after you first opened it even if it is not empty. Use a new vial.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Cystadrops contains

  • The active substance is cysteamine (mercaptamine), as hydrochloride. One mL of eye drops solution contains 3.8 mg of cysteamine.
  • The other ingredients are benzalkonium chloride (see section 2 under ‘Cystadrops contains benzalkonium chloride’), disodium edetate, carmellose sodium, citric acid monohydrate, sodium hydroxide, hydrochloric acid and water for injections.
What Cystadrops looks like and contents of the p

ack

Cystadrops is a clear and viscous eye drops solution.

Each box contains:

  • 1 amber glass vial containing 5 mL of eye drops solu

tion,

  • 1 dropper applicator.

Cystadrops is available in pack containing 1 box or in

multipack containing 4 boxes.

Not all pack sizes may be marketed in your country

Marketing Authorisation Holder/ Manufacturer

Recordati Rare Diseases

Tour Hekla

52 avenue du Général de Gaulle

92800 Puteaux - France

For any information about this medicine, please contact

the local representative of the Marketing Authorisation

Holder:

United Kingdom

Recordati Rare Diseases UK Ltd. Tel: +44 (0)1491 414333

This leaflet was last revised in 07/2025

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLGB 15266/0021

Last revision stated in the text: July 2025 · MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Cystadrops 3.8 mg/ml eye drops solution

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Active substance? Mercaptamine
Strength? 3.8 mg/ml
Pharmaceutical form? Eye drops
Viscous, clear solution.
How is it taken? Ocular
Excipients? Benzalkonium chloride, Disodium edetate, Carmellose sodium, Citric acid monohydrate, Sodium hydroxide (for pH adjustment), Hydrochloric acid (for pH adjustment), Water for injections
Pack sizes 5 ml
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life? 6 months
After first opening: 7 days. Store below 25°C. Do not refrigerate. Keep the dropper bottle tightly closed in the outer carton in order to protect from light.
Storage Before first opening:
Store in a refrigerator (2°C - 8°C).
Keep the vial in the outer carton in order to protect from light.
For storage conditions after first opening of the medicinal product, see section 6.3.
Drug group (ATC)? Ophtalmologicals, other ophtalmologicals
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01X Other ophthalmologicals
        1. S01XA Other ophthalmologicals
          1. S01XA21 mercaptamine
Marketing authorisation? PLGB 15266/0021 (first authorised 15 September 2021)
Marketing authorisation holder? Recordati Rare Diseases
Codes? GTIN 3663502000588 · BNF 11080100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.